Peter Verdult

Stock Analyst at Citigroup

(n/a)

# 4,492

Out of 4,497 analysts

2

Total ratings

n/a

Success rate

-46%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic Biotechnology

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	EVO Evotec SE	Upgrades: Buy	n/a	$4.70	-	1	Jun 8, 2023
	GLPG Galapagos NV	Upgrades: Buy	n/a	$26.16	-	1	Jan 27, 2022

Evotec SE

Jun 8, 2023

Upgrades: Buy

Price Target: n/a

Current: $4.70

Upside: -

Galapagos NV

Jan 27, 2022

Upgrades: Buy

Price Target: n/a

Current: $26.16

Upside: -